Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency - Takeaways - MDSpire

Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

  • By

  • Natalie J Nokoff

  • Cindy Buchanan

  • Jennifer M Barker

  • January 21, 2025

  • 0 min

Share

  • 1

    Classic congenital adrenal hyperplasia (CAH) is primarily caused by 21-hydroxylase deficiency, leading to adrenal insufficiency and excessive androgen secretion.

  • 2

    Newborn screening for CAH is crucial for early detection, preventing morbidity and mortality associated with missed diagnoses, especially in 46,XX infants.

  • 3

    Treatment for classic CAH involves glucocorticoid and mineralocorticoid replacement to manage adrenal insufficiency and reduce androgen excess.

  • 4

    Children with CAH may experience complications such as premature adrenarche, precocious puberty, and increased risks of hypertension and obesity.

  • 5

    Psychosocial support and surgical considerations are important for families managing the bodily differences associated with CAH in affected children.

Original Source(s)

Related Content